- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Cardiome Pharma Corp
+ Add to WatchlistCRME:US
1.9400 USD 0.00000.00%As of 17:20:00 ET on 05/24/2013.
Snapshot for Cardiome Pharma Corp (CRME)
| Open: | 1.9300 | Day's Range: | 1.9300 - 2.0000 | Volume: | 27,120 |
|---|---|---|---|---|---|
| Previous Close: | 1.9400 | 52wk Range: | 1.2000 - 2.6844 | 1-Yr Rtn: | -9.77% |
Key Statistics for CRME
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 6.6102 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | 0.2950 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 24.32 |
| Shares Outstanding (M) | 12.47 |
| 30 Day Average Volume | 70,465 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CRME
Company Profile & Key Executives for CRME
Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with clinical drug programs. The Company's programs focus on atrial arrhythmia and congestive heart failure.
| William L Hunter "Bill"President/CEO | Jennifer ArchibaldChief Financial Officer |
| Sheila M GrantChief Operating Officer | Donald A McAfee "Don"Chief Scientific Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CRME News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page